Eukaryotic Cell
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

EC Accepts, published online ahead of print on 29 June 2007
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
EC.00141-07v1
6/9/1562    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sugui, J. A.
Right arrow Articles by Kwon-Chung, K. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sugui, J. A.
Right arrow Articles by Kwon-Chung, K. J.

 Previous Article  |  Next Article 

Eukaryotic Cell doi:10.1128/EC.00141-07
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Gliotoxin is a virulence factor of Aspergillus fumigatus: gliP deletion attenuates virulence in mice immunosuppressed with hydrocortisone

Janyce A. Sugui, Julian Pardo, Yun C. Chang, Kol A. Zarember, Glenn Nardone, Eva M. Galvez, Arno Müllbacher, John I. Gallin, Markus M. Simon, and Kyung J. Kwon-Chung*

Laboratory of Clinical Infectious Diseases, Laboratory of Host Defense, Research Technology Branch, National Institutes of Health, Bethesda, Maryland., Max-Planck-Institute for Immunology, Freiburg, Germany., Institut für Physikalische Chemie, Freiburg Universität, Freiburg, Germany., John Curtin School of Medical Research, Australian National University, Canberra, Australia

* To whom correspondence should be addressed. Email: june_kwon-chung{at}nih.gov.


   Abstract

Gliotoxin is an immunosuppressive mycotoxin long suspected to be a potential virulence factor of Aspergillus fumigatus (AF). Recent studies using mutants lacking gliotoxin production, however, suggested that the mycotoxin is not important for pathogenesis of AF in neutropenic mice resulting from the treatment with cyclophosphomide and hydrocortisone. In this study, we report on the pathobiological role of gliotoxin in two different mouse strains, 129/Sv and BALB/c, that were immunosuppressed by hydrocortisone alone to avoid neutropenia. These strains of mice were infected using the isogenic set of a wild type (B-5233) and its mutant strain (gliP{Delta}), and the the glip reconstituted strain (gliPR). The gliP gene encodes a non-ribosomal peptide synthase that catalyzes the first step in gliotoxin biosynthes. The gliP{Delta} strain was significantly less virulent than B-5233 or gliPR in both mouse models. In vitro assays with culture filtrates (CFs) of B-5233, gliP{Delta} and gliPR strains showed the following: 1. Deletion of gliP abrogated gliotoxin production as determined by HPLC analysis; 2) Unlike the CFs from B-5233 and gliPR, gliP{Delta} CF failed to induce proapoptotic processes in EL4 thymoma cells, as tested by Bak conformational change, mitochondrial membrane potential disruption, superoxide production, caspase-3 activation and phosphatidylserine translocation. Furthermore, superoxide production in human neutrophils was strongly inhibited by CFs from B-5233 and gliPR, but not gliP{Delta}. Our study confirms that gliotoxin is an important virulence determinant of AF and that the type of the immunosuppression regimen used is important to reveal the pathogenic potential of gliotoxin.




This article has been cited by other articles:




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Appl. Environ. Microbiol. Infect. Immun. J. Bacteriol.
Mol. Cell Biol. Microbiol. Mol. Biol. Rev. ALL ASM JOURNALS
Copyright © 2007 by the American Society for Microbiology.